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Objectives: To study the role of HCV and HGV in PCT patients. 
Methods: 72 patients, all HCV-Ab positive divided in two 
p u p s :  40 PCT patients (31 sporadic and 9 familial) and 32 con- 
trol patients with HCV-related chronic liver disease. HCV and HGV 
viremia was tested by RT-nested PCR. The genotyping was per- 
formed by specific probes digoxigenin-11 dd UTP labeled; subtypes 
were identified by enzyme restriction and specific probes. 
D. Griso 
Results: 
HCV-RNA HCV-genotype PM (%) 
11 lb 1 2b 3 1-3 
PCT sporadic (31) 23 (76.6) 2 (8.6) 15 (65.2) 4 (17.4) - - 2 (8.6) 
PCT &nilid (9) 7 (77.8) 1 (14.3) 4 (57.2) 1 (14.3) - .- l(14.3) 
control panenu (32) 26 (81.2) 4 (15.4) 14 (53.8) 5 (19.2) - 1 (3.8) 2 (7.7) 
Conclusion: The presence of HCV-Ab was sigmficative in this 
series of subjects and a high percentage of PCT patients (76%) had 
HCV-RNA reflecting active viral replication. HGV-RNA resulted 
negative in all PCT patients. No differences were observed in the 
occurrence of HCV-RNA between sporadic PCT (74%) and familial 
PCT (77%). Analysis of genotypes showed that genotype l b  was 
predominant both in sporadic (15123) and in familial (417) PCT, 
as well as in patients with HCV-related disease (14126). Therefore, 
PCT patients positive for HCV-RNA should be tested for HCV 
genotype to better define a possible interferon treatment. 
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Objective: To clarify the effect and epidemiology of hepatitis G 
virus (HGV) infection on hemoddysis patients and chronic hepatitis 
C mfected patients. 
Patients and Methods: We studied 44 hemodialysis patients and 
19 patients chronically infected with hepatitis C virus treated with 
1FN-a. HGV-RNA was identified in serum by a reverse transcrip- 
tion-polymerase chain reaction assay with degenerated primers de- 
rived h m  the NS3 helicase region of the viral genome. The speci- 
ficity of the amplified products was assesed at 50°C using DNA en- 
zyme immunoassay (DEIA) and a 5'-biotinylated degenerated probe. 
Results: HGV-RNA was detected in 9 percent of the patients 
on hernodialysis (4 of 44). None of the patients had biochemical 
evidence of active liver &ease and none of them was infected with 
hepatitis C virus. 
On the other hand, HGV-RNA was detected in 7 of 19 patients 
chronically infected with hepatitis C virus (36.8%), being most of 
them intravenous drug users. There was no relationship between the 
presence of HGV and the response of HCV to interferon. 
Conclusions: This assay is a new, highly specific and rapid 
method for direct detection of HGV-RNA. 
The prevalence of HGV in the two populations is different. The 
rate of coinfechon between HGV and HCV is quite elevated. The 
prevalence in the context of dialysis can be linked to blood trans- 
fusions, though the possibility of nosocomial infection cannot be 
excluded. 
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Objectives: To study the prevalence of HGV infection in patients 
with chronic liver diseases and to examine its influence on disease 
activity. 
Methods: 254 indwiduals were screened for HGV using an 
ELISA PCR with HGV specific primers and probes. Of these, 100 
had histologically proven chronic hepatitis C, 26 primary bhuy  cir- 
rhosis (F'BC), and 30 alcoholic liver cirrhosis. 51 HBsAg positive and 
49 anti-hepatitis C virus (HCV) positive blood donors were tested 
as well. 
Results: HGV was detected in 18% of pts with chronic hepatitis 
C; in 32% of i.v. drug user, in 25% of transfusion associated chronic 
hepatitis C and in 8% of sporad~c HCV infection. 13% of pts with 
alcoholic liver cirrhosis, 11% of pts with PBC, 10% of anti-HCV 
positive and 2% of HBsAg positive blood donors were HGV positive. 
In pts with chronic HCV and HGV infection the most prevalent 
genotype was 3a whereas it was l b  in pts with HCV infection alone. 
Virus load and ALT levels did not M e r  in pts with HCV alone 
versus HCV and HGV coinfected pts (p = 0.3). Mild histology 
correlated with HGV coinfection 0, = 0.02). HGV had no influence 
on ALT levels and liver histology in pts with liver disease other than 
virally induced or in blood donors. 
Conclusions: HGV infection is common in HCV infected pts. 
in PBC and in alcoholic liver &ease. HGV codection in pts with 
chronic hepatitis C appears to have a favorable effect on the outcome 
of hepatitis. 
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Objectives: To create a system of HGV RNA detection and to 
analyze the prevalence of HGV in Poland 
Methods: Sera of 246 persons divided into six groups of high 
risk (IVDUs, patients with B and/or C hepatitis, longtime blood 
donors and hemophiliacs) were tested for HGV RNA. Total RNA 
was isolated as usual according to the Chomczynsky' method. cDNA 
was synthesized with random primers. For PCR amplification two 
primer pairs, recognizing nudeotide sequences of 5'UTR and NS5 
gene, were involved. The conditions for PCR were established. The 
PCR products were analyzed with agamse gel electrophoresis and 
verified in slot-blot hybridization assay with biotin-labeled probes. 
Results: Five samples were found to be HGV RNA positive. 
In these samples products of both primer pairs were obtained. All 
five samples were positive in hybridization tests. We &d not find 
samples positive with single primer pair or positive in electrophore- 
sishegative in hybridization assays. 
(1) The amplification and detection systems used look to be suffi- 
Conclusions: 
cient for HGV RNA identification. 
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(2) Prevalence of HGV RNA in Poland we estimate to be low, since 
it is low even in high risk groups. 
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Objective: To determine the presence of Hepatitis G Virus (HGV) 
in HIV lnfected patients and to relate it with infection by other 
parenterally transmitted hepatitis viruses (HCV, HBV) and with the 
risk factor to adcquire HIV mfection and transaminase levels. 
Patients and Methods: Serum samples h m  122 patients were 
studied. All were infected by HIV and 58% were IVDU, 54% had el- 
evated ALT levels, 58% were HCV positive and 66% had serological 
evidence of contact with HBV. HGV-RNA was detected using the 
Kit h m  Sorin BiomCdica, where the Core-region of HGV genome 
is amplified by the use of degenerated primers and the amplificate is 
detected through DEIA. 
Results: Overall, 29/122 patients had HGV-RNA (24%). Detec- 
tion of HGV-RNA at Merent groups was: 29% for HCV positive vs 
10% for HCV negative; 29% for HBV infection vs 12% for absence 
of contact; 25% for IVDU vs 22% for not IVDU; 26% when ALT 
elevation vs 21% for normal ALT. 
Conclusion: Active or past infection by other parenterally trans- 
mitted hepatitis viruses may be a stronger cofactor for HGV infection 
than ALT level or Intravenous Drug Use. 
Relation to Other Hepatitis Viruses 
lated and characterised: GB virus C (GBV-C) and a virus tentatively 
designated as hepatitis virus G (HGV). The new viruses exhibit a nu- 
cleotide sequence homology of about 85% and seem to be merent 
isolates of the same flavivirus. 
HGV was shown to have high prevalence in patients with kquent 
parented exposure. 
In 105 patients (40 with history of blood tlansfusion or blood 
products exposure, 13 on haemodialysis, 9 with organ transplan- 
tation, 35 with sporadic hepatitis) all positive for HCV-RNA by 
Amplicor (Roche Diagnostic Systems) we looked for the pres- 
ence of HGV-RNA by a reverse transcription PCR (F'CR-ELISA, 
Boehringer Mannheim) with primen h m  the 5'-NCR and NS5a 
and for the presence of GBV-C-RNA by a semi-nested reverse tran- 
scription PCR with primers proposed by Yoshiba et al., 1995. 
In 13 (12.4%) of the HCV-positive patients we were able to iden- 
hfy HGV and GBV-C RNA simultaneously. 
The frequency of HCV/HGV/GB-C virus comfection was 10% 
for blood transfusions or blood products (4 out of 40 patients), 31% 
for i.v. drug users, 22% for haemodialysis, 17% for renal transplanta- 
tion, 50% for liver transplantation and 3.3% for sporadic hepatitis. 
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Multiple Transfused Pediatric Patients 
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Objective: To evaluate the presence of Hepatitis G Virus (HGV) 
in haemodialysis patients, and its relation with Hepatitis C Virus 
Patients and Methods: Serum samples from 72 patients were 
studied. HCV serology was performed through 3d Gration EIA 
(Sorin BiomCdica) and RIBA 3.0 (Chiron). For HGV-RNA de- 
tection, total RNA was isolated using QUIAGEN spin colums and 
then reverse transcribed to cDNA by random priming in the pres- 
ence of AMV-Rr HGV-RNA was detected using the Kit h m  
Sorin BiomCdica, where the Core-region of HGV genome is ampli- 
fied by the use of degenerated primers and the amplificate is detected 
through DEIA-Hybridization. 
Results: Overall presence of HGV in the population studied was 
12.5%0.44/72 patients (61.1%) were negative for HCV serology and 
3/44 (6.8%) were infected by HGV; 28/72 patients (38.8%) were 
positive for HCV and 6/28 (21.4%) were infected by HGV 
Conclusion: Hepatitis G Virus was found at the expected rates 
for haemodialysis patients, though a sigdicative higher rate of de- 
tection was found for HCV positive patients. 
(HCV). 
Objective: To investigate the prevalence of HGV infection in pedi- 
atric multiple transfused patients. 
Methods: We studied 93 pedatric patients with cancer and 
hemoglobinopathy (35 acute leukemia, 8 lymphomas, 14 solid tu- 
mors, 29 thalassemia, 7 sickle cell anemia) to detect the HGV RNA 
and HCV RNA by RT-PCR. PCR procedure for GBV-C was 
performed according to the method reported by Egawa et al. All 
primer sequences were derived h m  a helicase-like codtng region of 
GBV-C. All sera were tested for Anti HCV with ELISA I11 (UBI 
HCV ELISA). 
Results: Of the patients, mean age was 8.6 f 4.3 years, mean 
number of transfusion was 34.87 f 61.73 and mean level of ALT 
was 63.26 zk 84.92 iu. Mean age and mean number of transfusion 
were higher in patients with hemoglobinopathies than in patients 
with cancer (p < 0.05). Of the total patients anti HCV was posi- 
tive in 11 (11.8%), HCV RNA was positive in 6 (6.5%) and HGV 
RNA was positive in 3 (3.2%). Prevalence of HGV RNA posi- 
tivity was 3.5% among pediatric cancer patients and 2.8% among 
hemoglobinopathies. While HGV RNA positivity was 3.7% among 
80 transfussed patients, we could not detect HGV RNA among 13 
nontransfused patients (p > 0.05). HGV RNA positive patients were 
negative for HCV RNA and for Anti HCV 
Conclusions: To investigate the multitransfused pediatric patients 
for HGV infection may be useful to prevent the post-transfusional 
hepatitis. 
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Two possible agents of non A-E hepatitis have been recently iso- 
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